§ 13F · FUND PROFILE
DAFNA Capital Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $404.8T (13F)Positions · 75Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$18.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 605K | $48.1T | 11.2% | −8% |
| 2 | XBI | SPDR S&P BIOTECH ETF | 337K | $41.0T | 9.5% | −16% |
| 3 | STXS | STEREOTAXIS INC | 13.68M | $31.5T | 7.3% | ±0% |
| 4 | ATRC | ATRICURE INC | 597K | $23.6T | 5.5% | +1% |
| 5 | CYTK | CYTOKINETICS INC | 371K | $23.6T | 5.5% | −6% |
| 6 | IDYA | IDEAYA BIOSCIENCES INC | 507K | $17.5T | 4.1% | −6% |
| 7 | AXGN | AXOGEN INC | 477K | $15.6T | 3.6% | −36% |
| 8 | XENE | XENON PHARMACEUTICALS INC | 288K | $12.9T | 3.0% | ±0% |
| 9 | IBB | ISHARES NASDAQ BIOTECH INDX | 68K | $11.5T | 2.7% | −34% |
| 10 | BHVN | BIOHAVEN LTD | 955K | $10.8T | 2.5% | +306% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE DAFNA SIGNAL
AC read
DAFNA Capital Management LLC is a Other fund managing $404785.9 trillion in assets. The fund runs a portfolio of 75 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed